Concepedia

Publication | Closed Access

Efficacy of triple therapy with rabeprazole for <i>Helicobacter pylori</i> infection and CYP2C19 genetic polymorphism

DOI

60

Citations

25

References

2001

Year

K Hokari, Toshiro Sugiyama, Mototsugu Kato, Masato Saito, Toshio Miyagishima, Masatoshi Kudo, Keiko Nishikawa, Jun Ishizuka, Yoshito Komatsu, T Mizushima,
Alimentary Pharmacology & Therapeutics

Abstract

Triple therapy with 10 mg of rabeprazole combined with amoxicillin/clarithromycin is effective for Japanese patients with H. pylori infection, and the H. pylori eradication rate is not affected by CYP2C19 genetic polymorphism.

References

YearCitations

Page 1